Raymond James & Associates’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-16,654
Closed -$627K – 3997
2024
Q1
$627K Sell
16,654
-55,097
-77% -$2.04M ﹤0.01% 2913
2023
Q4
$2.61M Buy
71,751
+56,810
+380% +$2M ﹤0.01% 1942
2023
Q3
$517K Sell
14,941
-41,435
-73% -$1.46M ﹤0.01% 2873
2023
Q2
$1.97M Sell
56,376
-300
-0.5% -$10.1K ﹤0.01% 2067
2023
Q1
$1.86M Sell
56,676
-20,786
-27% -$669K ﹤0.01% 2078
2022
Q4
$2.43M Buy
+77,462
New +$2.41M ﹤0.01% 1871

Other funds holding DOCT

Raymond James & Associates's DOCT Position: Q2 2024 in Review

Raymond James & Associates sold out of FT Vest US Equity Deep Buffer ETF October (DOCT) in Q2 2024, closing a stake of 16,654 shares — an estimated $627K sold.

Raymond James & Associates first reported a position in DOCT in Q4 2022 and held it in 6 quarters. The position peaked at $2.61M in Q4 2023. 65 funds tracked by Wall St. Rank hold DOCT as of Q2 2024.

  • Raymond James & Associates reported no remaining FT Vest US Equity Deep Buffer ETF October position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 16,654 FT Vest US Equity Deep Buffer ETF October shares in Q2 2024, an estimated $627K.
  • Raymond James & Associates first reported a position in FT Vest US Equity Deep Buffer ETF October in Q4 2022 and held it in 6 quarters.
  • Raymond James & Associates's FT Vest US Equity Deep Buffer ETF October position peaked at $2.61M in Q4 2023.
  • 65 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.